BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0860
+0.0160 (22.86%)
Sep 17, 2026, 3:34 PM AEST
BCAL Diagnostics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -7.37 | -7.24 | -6.4 | -5.06 | -3.39 |
Depreciation & Amortization | 0.7 | 0.95 | 0.57 | 0.11 | 0.02 |
Other Amortization | 0.02 | 0.05 | 0.01 | - | - |
Loss (Gain) From Sale of Assets | 0.12 | - | - | - | - |
Loss (Gain) From Sale of Investments | -0.16 | - | - | - | - |
Stock-Based Compensation | 0.32 | 0.69 | 0.63 | 0.23 | 0.37 |
Other Operating Activities | 0.22 | -0.02 | 0.05 | 0.04 | 0.01 |
Change in Accounts Receivable | 0.18 | 0.19 | 0.16 | -2.14 | -0.29 |
Change in Accounts Payable | -0.19 | -0.77 | 0.45 | 0.78 | 0.05 |
Operating Cash Flow | -6.16 | -6.14 | -4.52 | -6.05 | -3.22 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.46 | -0.79 | -1.15 | -0.36 | -0.03 |
Sale of Property, Plant & Equipment | 0.3 | - | - | - | - |
Investment in Securities | -1.28 | - | - | 4 | -4 |
Investing Cash Flow | -1.44 | -0.79 | -1.15 | 3.64 | -4.03 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 1.4 | 1.3 | - | - | - |
Long-Term Debt Issued | 5.1 | - | - | - | - |
Total Debt Issued | 6.5 | 1.3 | - | - | - |
Short-Term Debt Repaid | -1.58 | -0.22 | - | - | - |
Long-Term Debt Repaid | -0.26 | -0.29 | -0.44 | -0.04 | - |
Lease Payments | -0.26 | -0.29 | -0.18 | -0.04 | - |
Total Debt Repaid | -1.83 | -0.51 | -0.44 | -0.04 | - |
Net Debt Issued (Repaid) | 4.66 | 0.79 | -0.44 | -0.04 | - |
Issuance of Common Stock | - | 4.3 | 9.85 | 0.05 | 10.03 |
Other Financing Activities | - | -0.12 | -0.44 | - | -0.62 |
Financing Cash Flow | 4.66 | 4.97 | 8.97 | 0.01 | 9.41 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash Flow | -2.94 | -1.95 | 3.3 | -2.4 | 2.16 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -6.62 | -6.92 | -5.67 | -6.41 | -3.25 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -281.40% | -261.23% | -186.23% | -229.72% | -451.54% |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
Levered Free Cash Flow | -3.96 | -4.25 | -3.58 | -4.02 | -1.28 |
Unlevered Free Cash Flow | -3.74 | -4.2 | -3.52 | -4.01 | -1.28 |
Free Cash Flow After Leases | -6.88 | -7.22 | -5.85 | -6.45 | -3.25 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.15 | 0.09 | 0.1 | 0.02 | - |
Cash Income Tax Paid | -2.47 | -2.63 | -3.05 | -0.98 | -0.29 |
Change in Working Capital | -0.01 | -0.57 | 0.61 | -1.37 | -0.24 |